Arecor Therapeutics PLC Statistics
Want to see GB:AREC full AI Analyst Report?
Arecor Therapeutics PLC (AREC) Stock Statistics & Valuation Metrics
Total Valuation
Arecor Therapeutics PLC has a market cap or net worth of GBX 35.11M. The enterprise value is GBX 20.50M.
- Market Cap
- GBX 35.11M
- Enterprise Value
- GBX 20.50M
Share Statistics
Arecor Therapeutics PLC has 45,300,716 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,300,716
- Owned by Insiders
- 4.35%
- Owned by Institutions
- ―
Financial Efficiency
Arecor Therapeutics PLC’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -66.42%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- -66.42%
- Return on Capital Employed (ROCE)
- -0.72
- Revenue Per Employee
- 51.94K
- Profits Per Employee
- 20.12K
- Employee Count
- 33
- Asset Turnover
- 0.21
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Arecor Therapeutics PLC is 155.00. Arecor Therapeutics PLC’s PEG ratio is -3.79.
- PE Ratio
- 155.00
- PS Ratio
- -369.56
- PB Ratio
- 7.94
- Price to FCF
- -7.84
- Price to Operating Cash Flow
- -6.57
- PEG Ratio
- -3.79
Income Statement
In the last 12 months, Arecor Therapeutics PLC had revenue of 1.71M and earned 664.00K in profits. Earnings per share was 0.02.
- Revenue
- 1.71M
- Gross Profit
- 1.05M
- Operating Income
- -4.67M
- Pretax Income
- 994.00K
- Net Income
- 664.00K
- EBITDA
- -4.45M
- Earnings Per Share (EPS)
- 0.02
Cash Flow
In the last 12 months, operating cash flow was -4.45M and capital expenditures -26,000, giving a free cash flow of -4.48M billion.
- Operating Cash Flow
- -4.45M
- Free Cash Flow
- -4.48M
- Free Cash Flow per Share
- -0.12
Dividends & Yields
Arecor Therapeutics PLC pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.75%
- Earnings Yield
- 0.65%
Stock Price Statistics
- Beta
- 0.69
- 52-Week Price Change
- 4.73%
- 50-Day Moving Average
- 80.26
- 200-Day Moving Average
- 69.89
- Relative Strength Index (RSI)
- 37.90
- Average Volume (3m)
- 27.49K
Important Dates
Arecor Therapeutics PLC upcoming earnings date is Apr 27, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 30, 2026
- Next Earnings Date
- Apr 27, 2027
- Ex-Dividend Date
- ―
Financial Position
Arecor Therapeutics PLC as a current ratio of 4.35, with Debt / Equity ratio of 1.52%
- Current Ratio
- 4.35
- Quick Ratio
- 4.35
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.65
- Interest Coverage Ratio
- -424.18
Taxes
In the past 12 months, Arecor Therapeutics PLC has paid 62.00K in taxes.
- Income Tax
- 62.00K
- Effective Tax Rate
- 0.06
Enterprise Valuation
Arecor Therapeutics PLC EV to EBITDA ratio is -6.47, with an EV/FCF ratio of -7.49.
- EV to Sales
- -352.94
- EV to EBITDA
- -6.47
- EV to Free Cash Flow
- -7.49
- EV to Operating Cash Flow
- -7.53
Balance Sheet
Arecor Therapeutics PLC has GBX 3.15M in cash and marketable securities with GBX 57.00K in debt, giving a net cash position of GBX 3.10M billion.
- Cash & Marketable Securities
- GBX 3.15M
- Total Debt
- GBX 57.00K
- Net Cash
- GBX 3.10M
- Net Cash Per Share
- GBX 0.07
- Tangible Book Value Per Share
- GBX 0.10
Margins
Gross margin is -800.00%, with operating margin of 5113.68%, and net profit margin of -200.00%.
- Gross Margin
- -800.00%
- Operating Margin
- 5113.68%
- Pretax Margin
- -472.63%
- Net Profit Margin
- -200.00%
- EBITDA Margin
- 5455.79%
- EBIT Margin
- 5670.53%
Scores
- Smart Score
- 6
- AI Score
- 47

